Baker McKenzieâs Sanctions Blog published the alert titled Ukraine: Cancellation of marketing authorizations for pharmaceuticals manufactured in Russia or Belarus or held by companies affiliated or otherwise related to those with manufacturing facilities in Russia or Belarus on 25 May 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.
Author
Olha Demianiuk
Olha Demianiuk is a partner in Baker McKenzie's Corporate M&A Practice Group and the head of the Firm's Healthcare Industry Group in Kyiv. She has more than 11 years of experience advising local and international clients on M&A, private equity, equity capital market deals and corporate matters. Most recently Olha has been focusing on the healthcare sector advising clients on transactional, regulatory, commercial and other matters.